Medical Science On-line Open Peer Review Journal

Welcome to the Cybernetics Institute - Medical Science On-line Open Peer Review Journal. A new type of on-line science journal. This new type of science journal replaces the "peer" review journal with an open review journal that allows comments and critique from anyone. This change allows potential valuable insight from the public.

My Photo
Name:

I'm a new type of scientist that is not specific to one discipline - a mulitdisciplinary scientist. The theory (that was my PhD thesis) is published here; http://deltard.org . The medical science aspect of the theory is located at; ( http://medsci.cybernetics-institute.org) and qualifications are set under the new global irb/fda (institution review board/food & drug admin)and are based on more that 6 years of medical research. ( http://medsci-irb.cybernetics-institute.org)

Editor: Dr. Daniel Carras, PhD, DMSc, MD
Publisher: Akadhmia University Press
ISSN # 1715-3050
Vol.2, October 2007

Friday, March 24, 2006

Lab Notes

  1. This week has been a big week, after restructuring, work has begun on a new food lab to study the biochemistry of food in the body. It's well know that toxins in the environment pass through the food chain, but it's time to connect the last piece of the puzzle - humans. Toxins in the environment do have an effect in the body, the question is how much damage is being done, by what and at what levels. This study, with the new lab, will be indepth studying cancers and carcinogens, mutations and genetic engineering (natural and unnatural), tissue generation and regeneration, and anything else that can be done. Like all labs at Delta R&D, Inc. and The Cybernetics Institute - Medical Science, the exploratory research method will be used, allowing the research to dictate the direction.
  2. [Immunology] The weather has change significantly, shortening the winter flu season, and there has be no respiratory infections (flus, Hantavirus, etc.) in single patient clinical studies. Candidates for the study, were screened for high risk of infection. Candidates worked outdoors (or were outdoors significantly) and/or worked in areas in which rodents were present. Subsequently, the improvement has not been limited to air borne infections, seasonal allergies have also significantly improved with no need for medication. Work has begun to expand the clinical study to a larger number of patients.

Friday, March 10, 2006

Lab Notes

  1. Major restructuring is still going on, but should be complete by the end of March. Restructuring is required to add in new labs, organize library files and system (as it grows) - in general to provide new capacity for growth and new research.
  2. [Immunology] March, April and the first few weeks of May form the second half of the flu season. This means that June 1, 2006 will provide two full flu seasons of vastly improved immunity to the flu.
  3. [Clinical] Work has begun on a new patient portal that will take about six months to complete.

Saturday, March 04, 2006

Lab Notes

  1. While we got going again in January, there hasn't been all that much to report - in a weekly report. So, The Lab Report, which was The Weekly Lab Journal, has been simply renamed, Lab Notes. The goal is know to publish general information and lab notes. This will provide a greater degree of transparency and information on progress between paper publications. In fact, this is what you are seeing. Not polished science, but raw exploration as it happens. This publication allows the public and other scientist to look at the lab notes, see the mistakes, problems and progress.
  2. [Immunology] Work continues here with a few adjustments. It has been found that although a good base mechanism for dealing with air borne infection has been found, minor adjustments will be required as the immune system develops and changes. The body and immune system is more dynamic than previously expected.
  3. [Clinical] Its been found that Crestor has a significant interaction with some patients with bowel disorders. Adverse reactions with Crestor and the Advil have been observed, and dealt with successfully by removing the patient from Crestor.